From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement
FROM THE EDITOR

Welcome to the Gastrointestinal Stromal Tumor (GIST) Resource Center! Here you’ll find the latest information, education, research, and other resources that focus on GIST and the advanced practitioner’s role in delivering high-quality care to our patients. I'm excited to provide this information to you and your colleagues and hope this site is helpful to your practice. We’ve kicked things off with a video discussion introducing GIST to our viewers, where we defined the disease and reviewed risk factors, common symptoms, associated conditions, and how to distinguish it from other GI conditions. 
 
Please send your questions and/or comments about this Resource Center to jadpro-editor@conexiant.com.

Regan Cronin Moran, MSN, RN, AGNP-BC, AOCNP® 
Duke Cancer Institute

News & Literature Highlights

Clinical Cancer Research

Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors

Pharmaceutics

Tyrosine kinase inhibitors for gastrointestinal stromal tumor after imatinib resistance

Oncology Letters

Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

Clinical Cancer Research

Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)

Oncologist

The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: Desensitization therapy and pharmacogenetic investigation

Cancers

Multifocal gastrointestinal stromal tumors (GISTs) of the small intestine in patients with neurofibromatosis type 1 (NF-1): Meta-analysis and systematic review of the literature

Autophagy

Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity

Gastric Cancer

Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors

Laboratory Investigation; A Journal of Technical Methods and Pathology

Clinical use of liquid-based comprehensive genomic profiling in gastrointestinal stromal tumors

In Vivo

Low-dose imatinib efficacy in a gastrointestinal stromal tumor patient with KIT exon 11 W557_K558 deletion

Advertisement
Advertisement